CVE-2024-42176: Hcltech Dryice Myxalytics

High severity, CVSS 8.0. EPSS: 0.2% chance of exploitation in the next 30 days.

HCL MyXalytics is affected by concurrent login vulnerability. A concurrent login vulnerability occurs when simultaneous active sessions are allowed for a single credential allowing an attacker to potentially obtain access to a user's account or sensitive information.

Affected products

• Hcltech Dryice Myxalytics: version 6.3 only; version 6.4 only

Published 2025-03-19. Last modified 2026-06-17.